BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15991323)

  • 1. Gene symbol: SLC40A1. Disease: Primary iron overload.
    Zaahl MG; Merryweather-Clarke AT; Kotze MJ; van der Merwe S; Warnich L; Robson KJ
    Hum Genet; 2005 May; 116(6):541. PubMed ID: 15991323
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene symbol: SLC40A1. Disease: primary iron overload.
    Zaahl MG; Merryweather-Clarke AT; Kotze MJ; van der Merwe S; Warnich L; Robson KJ
    Hum Genet; 2005 Dec; 118(3-4):547. PubMed ID: 16521305
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene symbol: DCYTB/CYBRD1. Disease: primary iron overload.
    Zaahl MG; Merryweather-Clarke AT; Kotze MJ; van der Merwe S; Warnich L; Robson KJ
    Hum Genet; 2005 Dec; 118(3-4):546. PubMed ID: 16521301
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel mutations of the ferroportin gene (SLC40A1): analysis of 56 consecutive patients with unexplained iron overload.
    Pelucchi S; Mariani R; Salvioni A; Bonfadini S; Riva A; Bertola F; Trombini P; Piperno A
    Clin Genet; 2008 Feb; 73(2):171-8. PubMed ID: 18177470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel human pathological mutations. Gene symbol: SLC40A1. Disease: haemochromatosis, type 4.
    Relvas L; Claro MT; Bento MC; Ribeiro ML
    Hum Genet; 2009 Apr; 125(3):338. PubMed ID: 19309784
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel mutation in ferroportin implicated in iron overload.
    Wallace DF; Dixon JL; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN
    J Hepatol; 2007 May; 46(5):921-6. PubMed ID: 17383046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The homozygous mutation G75R in the human SLC11A2 gene leads to microcytic anaemia and iron overload.
    Barrios M; Moreno-Carralero MI; Cuadrado-Grande N; Baro M; Vivanco JL; Morán-Jiménez MJ
    Br J Haematol; 2012 May; 157(4):514-6. PubMed ID: 22313374
    [No Abstract]   [Full Text] [Related]  

  • 8. G80S-linked ferroportin disease: the first clinical description in a Greek family.
    Mougiou A; Pietrangelo A; Caleffi A; Kourakli A; Karakantza M; Zoumbos N
    Blood Cells Mol Dis; 2008; 41(1):138-9. PubMed ID: 18420432
    [No Abstract]   [Full Text] [Related]  

  • 9. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis.
    Wallace DF; Clark RM; Harley HA; Subramaniam VN
    J Hepatol; 2004 Apr; 40(4):710-3. PubMed ID: 15030991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of the E399D DMT1/NRAMP2/SLC11A2 protein produced by an exon 12 mutation in a patient with microcytic anemia and iron overload.
    Lam-Yuk-Tseung S; Mathieu M; Gros P
    Blood Cells Mol Dis; 2005; 35(2):212-6. PubMed ID: 16023393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro.
    Moreno-Carralero MI; Muñoz-Muñoz JA; Cuadrado-Grande N; López-Rodríguez R; José Hernández-Alfaro M; del-Castillo-Rueda A; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
    Am J Hematol; 2014 Jul; 89(7):689-94. PubMed ID: 24644245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel R416C mutation in human DMT1 (SLC11A2) displays pleiotropic effects on function and causes microcytic anemia and hepatic iron overload.
    Lam-Yuk-Tseung S; Camaschella C; Iolascon A; Gros P
    Blood Cells Mol Dis; 2006; 36(3):347-54. PubMed ID: 16584902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not all DMT1 mutations lead to iron overload.
    Blanco E; Kannengiesser C; Grandchamp B; Tasso M; Beaumont C
    Blood Cells Mol Dis; 2009; 43(2):199-201. PubMed ID: 19553145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC40A1-R178G mutation and ferroportin disease.
    Speletas M; Onoufriadis E; Kioumi A; Germenis AE
    J Hepatol; 2011 Sep; 55(3):730-731. PubMed ID: 21320560
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutation analysis of hepcidin and ferroportin genes in Italian prospective blood donors with iron overload.
    Duca L; Delbini P; Nava I; Vaja V; Fiorelli G; Cappellini MD
    Am J Hematol; 2009 Sep; 84(9):592-3. PubMed ID: 19610021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC40A1-R178G or R178Q and ferroportin disease? A call for vigilance in mutation reporting.
    Wallace DF
    J Hepatol; 2013 Aug; 59(2):396-7. PubMed ID: 23523714
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to: "SLC40A1-R178G or R178Q and ferroportin disease? A call for vigilance in mutation reporting".
    Speletas M; Kioumi A; Germenis AE
    J Hepatol; 2013 Aug; 59(2):397. PubMed ID: 23523713
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel missense mutation c.470 A>C (p.D157A) in the SLC40A1 gene as a cause of ferroportin disease in a family with hyperferritinaemia.
    Saja K; Bignell P; Robson K; Provan D
    Br J Haematol; 2010 Jun; 149(6):914-6. PubMed ID: 20230395
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional characterization of a novel SLC40A1 Arg88Ile mutation in a kindred with familial iron overload treated by phlebotomy.
    Womack J; Sukumaran A; Li X; Lozovatsky L; Gallagher PG; Seid JE; Finberg KE
    Blood Cells Mol Dis; 2021 Mar; 87():102532. PubMed ID: 33385755
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel ferroportin mutation in a Canadian family with autosomal dominant hemochromatosis.
    Morris TJ; Litvinova MM; Ralston D; Mattman A; Holmes D; Lockitch G
    Blood Cells Mol Dis; 2005; 35(3):309-14. PubMed ID: 16111902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.